|
MCCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.09840003338047E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.21459999625051E-08 |
| Normal-vs-Stage2 |
2.00899999999171E-05 |
| Normal-vs-Stage3 |
3.61999999975993E-08 |
| Normal-vs-Stage4 |
2.9827999999954E-06 |
| Stage1-vs-Stage2 |
7.638800E-01 |
| Stage1-vs-Stage3 |
1.290170E-01 |
| Stage1-vs-Stage4 |
3.006800E-01 |
| Stage2-vs-Stage3 |
4.041400E-01 |
| Stage2-vs-Stage4 |
3.544000E-01 |
| Stage3-vs-Stage4 |
7.668800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41469999445943E-08 |
| Normal-vs-AfricanAmerican |
1.82650006230745E-10 |
| Normal-vs-Asian |
3.655900E-02 |
| Caucasian-vs-AfricanAmerican |
6.246500E-02 |
| Caucasian-vs-Asian |
7.433600E-01 |
| AfricanAmerican-vs-Asian |
2.662200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26859997243656E-09 |
| Normal-vs-Female |
1.1912999999808E-06 |
| Male-vs-Female |
4.918200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.45539999996114E-06 |
| Normal-vs-Extreme_Weight |
1.21370025141232E-10 |
| Normal-vs-Obese |
2.89099999994935E-06 |
| Normal-vs-Extreme_Obese |
9.748400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.454000E-01 |
| Normal_Weight-vs-Obese |
9.636000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.683800E-01 |
| Extreme_Weight-vs-Obese |
6.201200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.011000E-01 |
| Obese-vs-Extreme_Obese |
5.520800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.12240000005315E-06 |
| Normal-vs-Age(41-60Yrs) |
2.00060000010716E-07 |
| Normal-vs-Age(61-80Yrs) |
7.87980000138688E-08 |
| Normal-vs-Age(81-100Yrs) |
2.351100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.340000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.633800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.359200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.931400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.737200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.119000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.38879999722619E-08 |
| Normal-VS-Type2 PRCC |
9.563600E-04 |
| Normal-VS-KIRP CIMP |
2.01980000502644E-08 |
| Normal-VS-Unclassified PRCC |
1.39800000020784E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.990800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.018810E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.845600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.599000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.334390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.962300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10780000009514E-07 |
| Normal-vs-N1 |
1.45169998244654E-09 |
| Normal-vs-N2 |
4.544200E-03 |
| N0-vs-N1 |
1.006610E-01 |
| N0-vs-N2 |
5.500400E-01 |
| N1-vs-N2 |
9.418400E-01 |
|
|
